Freyr provides Japan Drug Registration and Approval support for pharmaceutical manufacturers that includes product classification, registration and approval for regulatory compliance as per PMDA regulations. As of 2024, Japan’s pharmaceutical market has continued to grow steadily, with sales reaching $67.5 billion, further solidifying its position as the third-largest pharmaceutical market globally, following the United States and China.